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treatment stool cultures, all larvae obtained were classiﬁed as
cyathostomes. Benzimidazoles resistance is widespread in the
central area of Argentina [3] . In this context, the use of these drugs
to control small strongyles could be currently inadvisable unless
controls are carried out post treatment to establish efﬁcacy
thereof. Practitioners need to determine if anthelmintic resis-
tance is present before advice control parasite programs. Pres-
ently, FECRT is the most appropriate method for these practices
and should be used regularly to monitor the resistance status on
horse farms.
Acnowledgements
Financial support was obtained from INTA (National Institute of
Agricultural Technology from Argentina) CIAC 940143 ﬁnancial
support was obtained from INTA CIAC 940143.
References
[1] 1Anziani OS., Catanzaritti H. (2005). Resistencia a los
benzimidazoles en nematodes de los equinos en Santa
Fe, Argentina. Veterinaria Argentina . 218: 571-578.
[2] Dobson RJ.; Hosking BC.; Jacobson CL.; Cotter JL.;
Bessier RB.; Stein PA.; Reid SA.(2012). Preserving new
anthelmintics: a simple method for estimating faecal
egg count reductions test (FECRT) conﬁdence limits
when efﬁcacy and/or nematodos aggregation is high.
Veterinary Parasitology.186:79-92.
[3] Cerutti J, Cooper L, Caffe G, Muchiut S, Anziani OS.
(2012). Resistencia de los peque~nos estrongilos equinos
a los bencimidazoles en el area central de la Argentina.
InVet (Bs As , Argentina)14: 41-46.
125
Isolation of Sarcocystis neurona from an opossum
(Didelphis albiventris) in Argentina
G. More*1,2, M. Rambeaud 1, F. Braun 3, L.M. Campero 1,2, A.
Walkoski 3, M.C. Venturini 1
1 Laboratorio de Inmunoparasitología, FCV-UNLP, La Plata, Buenos
Aires, Argentina; 2Consejo Nacional de Investigaciones Cientíﬁcas
y Tecnicas (CONICET), Buenos Aires, Argentina; 3 Private activitySarcocystis neurona is an Apicomplexan parasite which affects a
wide range of animal hosts. This protozoan is the main cause of
equine protozoal myeloecephalitis (EPM) in Western Hemisphere
horses. The parasite reproduces sexually in the intestine of
deﬁnitive hosts (DH) and asexually in tissues of intermediate and
aberrant hosts. The geographical distribution of S. neurona is
related with the distribution its deﬁnitive hosts, the opossums
Didelphis virginiana and D. albiventris. A recent serological study
conducted in Argentinean horses using S. neurona antigen
revealed an overall seroprevalence of 26.1%. However, the parasite
has not been isolated in Argentina. Tissues from an opossum (D.
albiventris) hunted by dogs in a farm from the central region of
Buenos Aires province were collected. Horses raised in the farm
showed a 50% (10/20) S. neurona seroprevalence. One seropositive
horse developed neurological signs and evidenced clinical
improvement after a 2 month treatment with Ponazuril. A com-
plete necropsy of the opossum was conducted and the intestinal
mucosal scraping was subjected to a parasitological study withsucrose solution. A high amount of Sarcocystis spp. oocysts/spo-
rocysts were observed (Fig. 1). DNA was extracted from concen-
trated oocysts with a commercial kit (ZR Fecal DNA, Zymo
Research). The sample was identiﬁed as S. neurona by speciﬁc
PCR-restriction fragment length polymorphism (RFLP) and by
sequencing of a fragment of the 18S rRNA gene. Approximately 5 x
105 oocysts were subjected to a pepsin-HCl digestion followed by
a physical disruption. Released sporozoites were used to infect
fresh BM cell cultures, maintained by 3 passages during 2 months
and further preserved in liquid nitrogen. This study represents the
ﬁrst isolation of S. neurona in Argentina. Further studies will be
conducted in order to identify antigen expression as well as to
compare genetic characteristics between the isolated strain and
reference strains.
Figure 1. Sarcocystis spp. oocysts collected from opossum intestinal scrap-
ping after sucrose ﬂotation.
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Dourine is caused by the protozoan parasite Trypanosoma equi-
perdum and is a serious, often chronic, venereally transmitted
disease of horses and other equids. Once widespread, Dourine
has been eradicated from many countries but may still be
detected in horses in Asia, Africa, South America, Southern and
Eastern Europe, Mexico and Russia. It was reported in June 2011
in Sicily and north of Naples, on the Italian mainland [1]. Dourine
is an OIE listed notiﬁable disease. Laboratory diagnosis of
Dourine is performed through serological tests such as CFT, IFAT
and ELISA. The OIE recommended test for international trade of
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have shown that CFT cannot differentiate between species of
Trypanosoma as the CFT is not species speciﬁc [5]. The diagnostic
signiﬁcance of this test is therefore doubtful in countries where
both T. equiperdum and T. evansi infections occur. Human
sleeping sickness [6] caused by T. gambiense and surra in camels
caused by T. evansi [2] can be diagnosed with T. equiperdum
antigen. In collaboration with the Instituto G. Caporale, Teramo,
Italy, we received 8 conﬁrmed Dourine positive equine sera
samples of different titres collected during the Italian outbreak
in 2011 [4]. These 8 sera were further tested at CVRL using an-
tigen preparations from 7 different T. equiperdum strains
including ITMAS 170108 (OVI), ITMAS 070109 (Botat), ITMAS
261003B 943 (Ethiopian), ITMAS 220101 (American), ITMAS
211199A (French), ITMAS 241199B (German), ITMAS 290101
(Canadian), as well as T. evansi strain. T. evansi strainwas isolated
from a dromedary in Dubai [3]. The results of these in-
vestigations are summarized in Table 1. As seen from the Table, 8
sera reacted with different titres against different T. equiperdum
strains as well as T. evansi. This proves that standardization of T.
equiperdum antigen for use in CFT is an important issue.Table 1
CFT results of 8 Dourine-positive Italian horse sera using T. evansi and different strains of T. equiperdum antigens
SAMPLE ID CVRL CFT CFT CVRL CFT ** (with different T. equiperdum strains)
T. evansi* Teramo, Italy Ethiopian Ag Ovi Ag French Ag Canadian Ag German Ag BoTat Ag American Ag
NAM 3 1:20++++ 1:320++ 1:160+ 1:80++ 1:40++ 1:40+++ 1:80++++ 1:80+ 1:80+
NAM 4 1:40++ 1:640++ 1:160++ 1:80++ 1:40++ 1:80+ 1:160+ 1:80+ 1:80+++
BATCH 0036 1:20+++ 1:2560 1:40+ 1:40+++ 1:40+ 1:40+ 1:80+ 1:20++ 1:80++
BATCH 0037 1:20+ 1:160 1:40++ 1:40+++ 1:20+ 1:40+ 1:80+ 1:40+ 1:40++
BATCH 0039 Negative 1:10 1:2++ 1:5++ 1:2+ 1:2+ 1:5++ 1:2++ 1:5++
BATCH 0038 1:160+ 1:2560 1:640++ 1:320++ 1:320+ 1:320+ 1:320+ 1:320+ 1:640++
BATCH 0040 1:10++++ 1:160 1:40+ 1:40+ 1:20+ 1:10+++ 1:80+ 1:20++ 1:40++
BATCH 0041 1:5++++ 1:160 1:10+ 1:5+++ 1:2+++ 1:5+++ 1:10++ 1:10+ 1:5+++*The optimum dilution of T. evansi antigen for CFT testing has
been obtained by performing checker board with T. evansi posi-
tive serum
**The optimum dilution of different isolates of T. equiperdum
antigen for CFT testing has been obtained by performing checker
board with T. equiperdum positive serum.
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A molecular survey of equine piroplasms was conducted using
samples collected from symptomatic and asymptomatic horses of
Central Italy. Case deﬁnition for the acute form of piroplasmosis
was temperature >38C and at least one of the following signs,
jaundice, anaemia and petechial haemorrhages, and a PCR posi-
tive result. Phylogenetic analysis was conducted on sequences of
78 blood samples collected in 2013/14, having either low Ct values
in real-time PCRs (46 samples) for the parasites or a PCR pos/
ELISA neg (VMRD, USA) result (32 samples). Sequencing was
performed on the V4 hypervariable region of the 18S rRNA genewhich was 390 bp for B. caballi and 430 for T. equi [1, 2]. Using
BLAST, sequences were aligned with those deposited in GenBank
for both piroplasms, having a minimum 98% query coverage and
>97% homology. Genetic distance and homology conﬁrmed that
sequences of both parasites could be divided into the 3 groups,
with a homology among the groups >97% [1, 2]. Group 1 included
sequences homologous to ﬁrst-ever reported piroplasms, group 2
to the “like genotypes” [1], and group 3 included those with
equidistant homology for the two groups [2]. Among the 72 se-
quences identiﬁed as T. equi, 39 belonged to group 1, 24 to group
2, and 9 to group 3. Group 1 included 62% (24/39) of the se-
quences of symptomatic horses, while 96% (23/24) of T. equi like
(group 2), were from asymptomatic horses. Studies report that
sequences within group 1 and 2 are in all endemic areas, while in
America only group 1 and 3 are present. To date, sequences
belonging to Group 3 were never submitted for Europe and Asia.
Of the 27 T. equi PCRpos/ELISAneg samples, 23 (85.1%) had Group
1 sequences with 19 of them from symptomatic horses. For B.
caballi, 7 sequences were obtained, of which only 2 were from
horses positive for ELISA, 4 belong to group 1, 1 to group 2, and 2
to group 3. No clinical signiﬁcance was attributed to this parasite
due to the limited number of sequences available. Sequences
within the same groups and their wide geographic distribution
suggest that the diversity could be independent from their origin
and probably linked with the international movement of equidae.
The present study is the ﬁrst to report group 3 for both parasites
